Search for Clinical Trial Results
Leukemia, Plasma Cell - 19 Studies Found
| Status | Study |
| Completed |
Study Name: Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia Condition: Primary Plasma Cell Leukemia Date: 2012-03-03 Interventions: Drug: Lenalidomide, dexamethasone Enrolled patients receiv |
| Completed |
Study Name: Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia Condition:
Date: 2011-03-29 Interventions:
|
| Terminated |
Study Name: Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma Condition:
Date: 2012-08-03 Interventions:
|
| Completed |
Study Name: Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70 Condition: Multiple Myeloma Date: 2016-08-04 Interventions: Drug: PAD-VCD 12 weeks of induction chemotherapy by liposomal Bortezomib-Dexamethasone-Doxorubicin (PAD) |
| Completed |
Study Name: Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants Condition:
Date: 2006-03-23 Interventions:
|
| Completed |
Study Name: A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Condition: Multiple Myeloma, Plasma Cell Leukemia Date: 2010-11-24 Interventions:
|
| Recruiting |
Study Name: Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma Condition:
Date: 2015-07-20 Interventions:
|
| Withdrawn |
Study Name: Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma Condition:
Date: 2014-12-09 Interventions: Drug: Bendamustine Given IV Other Names: |
| Completed |
Study Name: A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma Condition:
Date: 2009-01-09 Interventions:
|
| Terminated |
Study Name: Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen Condition:
Date: 2008-01-22 Interventions:
|